RESUMEN
Tacrolimus is an immunomodulatory drug, available for topical and systemic treatment of several dermopathies that are characterized by immune dysregulation. In the case of alopecia areata, standard application has proven insufficient to yield satisfactory results. Herein, we present a 6-year-old patient with Down syndrome who was treated with topical tacrolimus 0.1% ointment under occlusion overnight with remarkable clinical improvement within 4 months.
Asunto(s)
Alopecia Areata , Tacrolimus , Administración Cutánea , Administración Tópica , Alopecia Areata/tratamiento farmacológico , Niño , Humanos , Tacrolimus/uso terapéutico , Resultado del TratamientoAsunto(s)
Escabiosis , Humanos , Ivermectina , Escabiosis/diagnóstico , Escabiosis/tratamiento farmacológico , PielRESUMEN
We present a rare case of crusted scabies in an human T-cell lymphotropic virus type 1 (HTLV-1) infected woman prior to onset of adult T-cell leukemia/lymphoma (ATL). We highlight the importance of this rare form of scabies as a prediagnostic sign of ATL, requiring high suspicion and monitoring of possible symptoms for early detection of ATL.
